Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Peer Review reports

From: CTLA4+CD4+CXCR5−FOXP3+ T cells associate with unfavorable outcome in patients with chronic HBV infection

Original Submission
30 Jun 2022 Submitted Original manuscript
11 Aug 2022 Reviewed Reviewer Report
5 Nov 2022 Reviewed Reviewer Report
8 Nov 2022 Reviewed Reviewer Report
22 Nov 2022 Author responded Author comments - Yongyin Li
Resubmission - Version 2
22 Nov 2022 Submitted Manuscript version 2
27 Nov 2022 Reviewed Reviewer Report
28 Nov 2022 Reviewed Reviewer Report
17 Dec 2022 Author responded Author comments - Yongyin Li
Resubmission - Version 3
17 Dec 2022 Submitted Manuscript version 3
22 Dec 2022 Reviewed Reviewer Report
26 Dec 2022 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
27 Dec 2022 Editorially accepted
12 Jan 2023 Article published 10.1186/s12865-022-00537-w

You can find further information about peer review here.

Back to article page

BMC Immunology

ISSN: 1471-2172

Contact us